Enjoy complimentary customisation on priority with our Enterprise License!
The apheresis devices market share is expected to increase by USD 915.84 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 6.3%.
The apheresis devices market research report provides valuable insights into the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentation by product (systems and consumables) and geography (North America, Europe, Asia, and Rest of World (ROW)).
The market report also offers information on several market vendors, including Medica SpA, Asahi Kasei Corp., B. Braun SE, BioIVT LLC, Cerus Corp., Charles River Laboratories International Inc., Demophorius Ltd, Fresenius Medical Care AG and Co. KGaA, Haemonetics Corp., Haier Biomedical, Infomed SA, Kaneka Medix Corp., Kawasumi Laboratories Inc, Lmb Technologie GmbH, Mallinckrodt Plc, Miltenyi Biotec B.V. and Co. KG, Nikkiso Co. Ltd., OTSUKA ELECTRONICS CO. LTD, Sichuan Nigale Biomedical Co. Ltd, and Terumo Corp. among others.
Asahi Kasei Corp. is a public company headquartered in Japan. It is a global company generating USD 18,954.46 million in revenues and has around 44,497 employees. Its revenue from the global apheresis devices market contributes to its overall revenues along with its other offerings, but it is not a key revenue stream for the company. The company offers Plasauto which is blood purification equipment.
Get the Apheresis Devices Market Size Forecast by Downloading the Report Sample
Technavio categorizes the global apheresis devices market as a part of the global healthcare equipment market. Our research report extensively covers external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the apheresis devices market during the forecast period.
Based on our research output, there has been a positive impact on the market growth during and post-COVID-19 era. The increasing prevalence of chronic diseases is notably driving the market growth, although factors such as the high costs associated with apheresis devices and procedures may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Key Market Driver
Key Market Trend
Key Market Challenge
This market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Our In-house experts produce extensive information on the value chain and parent market of the apheresis devices market, which vendors can leverage to gain a competitive advantage during the forecast period. The Value Chain information provides an end-to-end understanding of product insight and profit and also optimization and evaluation of business strategies. The players across the value chain include selective data and analysis from entire research findings as per the scope of the report.
Get a glance at the market share of various regions by Requesting a PDF sample now!
41% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for apheresis devices in North America. Market growth in this region will be faster than the growth of the market in the Rest of World (ROW).
The increasing prevalence of CVDs and neurological disorders, a growing number of surgical procedures, rising adoption of technologically advanced medical devices, increasing awareness among healthcare professionals about the apheresis procedure, and rising healthcare expenditure will facilitate market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
COVID-19 has spread widely across North America, especially in the US, which is expected to hinder the growth of the regional market. This is because of the temporary shutdown of manufacturing units of vendors and various end-user industries, which led to a decline in the revenue of healthcare services in North American countries, such as the US, Canada, and Mexico. However, the market is expected to witness the resumption of operations in the healthcare units due to large-scale vaccination drives. This will result in a higher inflow of patients during the forecast period.
Request for a FREE sample to gain insights into the market contribution of various segments
The market share growth by the systems segment will be significant during the forecast period. Apheresis systems are used to receive blood from donors or patients and separate it into various components such as plasma, platelets, red blood cells, and white blood cells. The increasing number of surgical procedures, growing demand for blood components, rising prevalence of chronic diseases, increasing awareness about the apheresis procedure among people, and growing technological advances are the major factors that are driving the growth of the global market.
This report provides an accurate prediction of the contribution of all the segments to the growth of the apheresis devices market size and actionable market insights on the post-COVID-19 impact on each segment.
|
Apheresis Devices Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
120 |
|
Base year |
2021 |
|
Forecast period |
2022-2026 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 6.3% |
|
Market growth 2022-2026 |
$ 915.84 million |
|
Market structure |
Fragmented |
|
YoY growth (%) |
5.7 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 41% |
|
Key consumer countries |
US, Canada, Germany, UK, and France |
|
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
|
Key companies profiled |
Medica SpA, Asahi Kasei Corp., B. Braun SE, BioIVT LLC, Cerus Corp., Charles River Laboratories International Inc., Demophorius Ltd, Fresenius Medical Care AG and Co. KGaA, Haemonetics Corp., Haier Biomedical, Infomed SA, Kaneka Medix Corp., Kawasumi Laboratories Inc, Lmb Technologie GmbH, Mallinckrodt Plc, Miltenyi Biotec B.V. and Co. KG, Nikkiso Co. Ltd., OTSUKA ELECTRONICS CO. LTD, Sichuan Nigale Biomedical Co. Ltd, and Terumo Corp. |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Product
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Certified ISO 9001 : 2015
We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.
We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.
Get lifetime access to our
Technavio Insights
Customized Report as per your Business Needs
Let us help you make report more suited to your requirements.
Get the report (PDF) sent to your email within minutes.
